https://www.selleckchem.com/TGF-beta.html
5cm internal planning volume (ITV). Median RT dose to CTV_eval was 50.4Gy (45.0-50.4). Median 95% CTV_eval coverage was 99.5% (95-10. OSLD readings were available for 8 patients and correlated to the dose measurements in the treatment planning system (TPS); median OSLD ratio was 0.99 (range, 0.93-1.02). Delivering PMRT with PBS for women with metal-containing TEs using a hybrid SFO/MFO technique is feasible, reproducible, and achieves excellent dose distributions. Additional techniques are required to safely utilize this treatment in the clin